🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is evaluating the Pharmacokinetics of MNTX in healthy control su...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2004-03
Trial ID
NCT01367509
Treatments Being Tested
This double-blind, randomized, two-cohort, placebo-controlled, parallel gro...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2006-10
Trial ID
NCT01366365
Treatments Being Tested
This is an open-label, radiotracer study, to be conducted in healthy, norma...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2005-06
Trial ID
NCT01367483
Treatments Being Tested
Ticagrelor is associated with more prompt and potent antiplatelet effects c...
Status
Completed
Location
University of Florida
Start Date
2015-08
Trial ID
NCT02403830
Treatments Being Tested
To test the effectiveness of MNTX in advanced illness subjects....
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2003-02
Trial ID
NCT00401362
Treatments Being Tested
This was a single-center, double-blind, randomized, cross-over Phase 1 stud...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2004-02
Trial ID
NCT01366352
Treatments Being Tested
This is an open label compassionate use study of subcutaneously administere...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2003-01-24
Trial ID
NCT01368562
Treatments Being Tested
This open-label study assesses the single-dose pharmacokinetics of intraven...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2007-01
Trial ID
NCT01366378
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of methylnaltrexone i...
Status
Completed
Location
Fletcher Allen Health Care
Start Date
2009-10
Trial ID
NCT01004393
Treatments Being Tested
This is a multicenter, non-randomized, single-dose, parallel-group study. E...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2004-03
Trial ID
NCT01367522
Treatments Being Tested